Abstract
Backround: Ginkgo biloba extract (GBE) is one of the most widely used extracts in food supplements and herbal medicines with wide spectrum of activities.
Introduction: Extracts of Ginkgo leaves contain biologically active flavonoid glycosides from different types mainly flavonol derivatives such as rutin. The amounts of flavone glycosides, one of the key active components in GBE, vary in accordance with the source of the Ginkgo leaves and the extraction and other used procedures.
Method: With respect to quality control optimization solutions, a simple, precise, accurate and reproducible HPLC method for assay of flavonol glucoside rutin is developed and applied to supplements containing GBE. The method is based on the use of isocratic mobile phase regimen with UV detection.
Result: Rutin is successfully separated using 4.6 x 150 mm column RP-18, ODS with particle size 5 m without preliminary hydrolysis. The proposed method is validated in accordance with ICH and European Pharmacopoeia 8.0 requirements and compared with HPLC methods in European Pharmacopoeia and US Pharmacopoeia.
Conclusion: The proposed method could be applicable for identification, purity and assay tests of supplements containing Ginkgo biloba extract according to Pharmacopoeia requirements.
Keywords: Ginkgo biloba extract, rutin, quality control, HPLC.
Current Pharmaceutical Analysis
Title:Quality Control Optimization Solutions for Determination of Rutin in Supplements Containing Ginkgo Biloba Extract
Volume: 12 Issue: 4
Author(s): Ivanka P. Pencheva, Vania N. Maslarska, Assena C. Stoimenova, Manoela M. Manova, Lily A. Andonova and Petranka K. Zdraveva
Affiliation:
Keywords: Ginkgo biloba extract, rutin, quality control, HPLC.
Abstract: Backround: Ginkgo biloba extract (GBE) is one of the most widely used extracts in food supplements and herbal medicines with wide spectrum of activities.
Introduction: Extracts of Ginkgo leaves contain biologically active flavonoid glycosides from different types mainly flavonol derivatives such as rutin. The amounts of flavone glycosides, one of the key active components in GBE, vary in accordance with the source of the Ginkgo leaves and the extraction and other used procedures.
Method: With respect to quality control optimization solutions, a simple, precise, accurate and reproducible HPLC method for assay of flavonol glucoside rutin is developed and applied to supplements containing GBE. The method is based on the use of isocratic mobile phase regimen with UV detection.
Result: Rutin is successfully separated using 4.6 x 150 mm column RP-18, ODS with particle size 5 m without preliminary hydrolysis. The proposed method is validated in accordance with ICH and European Pharmacopoeia 8.0 requirements and compared with HPLC methods in European Pharmacopoeia and US Pharmacopoeia.
Conclusion: The proposed method could be applicable for identification, purity and assay tests of supplements containing Ginkgo biloba extract according to Pharmacopoeia requirements.
Export Options
About this article
Cite this article as:
Pencheva P. Ivanka, Maslarska N. Vania, Stoimenova C. Assena, Manova M. Manoela, Andonova A. Lily and Zdraveva K. Petranka, Quality Control Optimization Solutions for Determination of Rutin in Supplements Containing Ginkgo Biloba Extract, Current Pharmaceutical Analysis 2016; 12(4) . https://dx.doi.org/10.2174/1573412912666160212000457
DOI https://dx.doi.org/10.2174/1573412912666160212000457 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents Oxidative Stress: Apoptosis in Neuronal Injury
Current Alzheimer Research Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Biochemical Differentiation of Cholinesterases from Normal and Alzheimers Disease Cortex
Current Alzheimer Research Meet Our Editorial Board Member
Current Aging Science Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry Acetylcholinesterase Inhibition in Alzheimers Disease
Current Pharmaceutical Design Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings
CNS & Neurological Disorders - Drug Targets Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Current Neuropharmacology Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Current Drug Targets New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges
Current Medicinal Chemistry GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
Current Alzheimer Research A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease
Current Molecular Pharmacology Cognitive and Cardiovascular Benefits of Docosahexaenoic Acid in Aging and Cognitive Decline
Current Alzheimer Research Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design